Central Proteina Prima Tbk. vs Dharma Polimetal Tbk. — how do they compare? Central Proteina Prima Tbk. trades at Rp50 (market cap 2.98T, 2.22M 24h volume), while Dharma Polimetal Tbk. trades at Rp930 (market cap 4.35T, 825.7K 24h volume). The key difference: Dharma Polimetal Tbk. is the larger of the two by market cap, and Central Proteina Prima Tbk. is more actively traded (2.22M versus 825.7K). Which is the better fit depends on your goals.
| CPRO | DRMA | |
|---|---|---|
Market Cap | 2.98T | 4.35T |
Volume | 2.22M | 825.7K |
Lot | 22.16K | 8.26K |
Turnover | 110.81M | 768.05M |
Average Price | 50 | 930.18 |
Value | 110.81M | 768.05M |
Indicative Equilibrium Price | 50 | 930 |
Indicative Equilibrium Volume | 32 | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT Central Proteinprima Tbk (The Company) was established on April 30, 1980 based on the Domestic Capital Investment Law No. 6 year 1968. Base on notarial deed no. 45 dated Dec 7, 1989 the company's share holders agreed offering 1.000.000 share to public, increase paid up capital and authorized capital. At 14 May 1990, the company's shares were treadeable in Jakarta Stock Exchange.Base on notarial deed no.7 dated 4 Oct 2004 of Fahiah Helmi, SH, the company was changed to private company. At Nov 5, 2004, base on JSX letter no S-1671/BEJ-PSR/11-2004 the company was delisted. And then at Sep 2004, the Company's ownership was changed to foreign investment. The Company’s articles of association has been amended several times, most recently by notarial deed No. 57 of Lies Herminingsih, S.H., dated Sep 30, 2006, concerning change of director's job description.
Read more on CPRO →PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.
Read more on DRMA →